The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

MEDI-NEWS - Based on Guidelines Prepared by the Meningococcal B Pilot Project Task Group

Young Infants and the Multi-Component Serogroup B Vaccine: New NACI Recommendations for Healthcare Professionals

March 26, 2014

Invasive meningococcal disease (IMD) is an acute and serious infection caused by the bacterium Neisseria meningitidis. In Canada, 5 serogroups are responsible for IMD, of which serogroup B is now the most prevalent, especially among infants...

PRIORITY PRESS - 7th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)

New Treatment Strategies for Prophylaxis in Severe Hemophilia: Moving from Clinical Trials into Real World Practice

Brussels, Belgium / February 26-28, 2014

Brussels - The focus of care in hemophilia A and B has shifted from the management of acute bleeding episodes (on-demand therapy) toward prophylaxis to prevent bleeding episodes and disease sequelae. Currently, hemophilia A patients...

PHYSICIAN PERSPECTIVE - Viewpoint based on current literature and presentations from the 19th Canadian Digestive Disease Week (CDDW) & 8th Annual CASL Winter Meeting

Update on Bowel Preparation Agents: Considering Efficacy, Tolerability and Safety for Optimal Compliance

Toronto, Ontario / February 8-11, 2014

Guest Editors:Stephen VannerProfessor of Medicine and PhysiologyQueen’s UniversityKingston, Ontario  Lawrence HookeyAssociate Professor of MedicineQueen’s UniversityKingston, Ontario Introduction The effectiveness of...

MEDICAL FRONTIERS - 9th Congress of the European Crohn's and colitis Organisation (ECCO-IBD 2014)

New Insights into Strategies for Management of Crohn’s Disease and Ulcerative Colitis

Copenhagen, Denmark / February 20-22, 2014

Copenhagen - Numerous clinical trials have demonstrated the therapeutic value of treatment with monoclonal anti-TNF-a antibodies such as infliximab and adalimumab in luminal and/or fistulizing Crohn’s disease or ulcerative colitis,...


Perspectives on Pulmonary Arterial Hypertension (PAH) - Reviews from published literature

February 2014

The 6-Minute Walk Test: Rethinking Outcome Measures in PAH Editorial ReviewWritten by: Theodore Bosworth Paul Hernandez, MDCM, FRCPCRespirologist, QEII Health Sciences CentreProfessor, Department of MedicineDalhousie UniversityHalifax,...

PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from Vascular 2013

SGLT2 Inhibitors: A Multi-Pronged Tool Against Type 2 Diabetes

Montreal, Quebec / October 17-20, 2013

Guest Editors: Philip A. McFarlane, MD, PhD, FRCPCDivision of NephrologySt. Michael’s HospitalUniversity of TorontoToronto, Ontario Ronald M. Goldenberg, MD, FRCPC, FACELMC Diabetes & EndocrinologyThornhill,...

PRIORITY PRESS - 55th Annual Meeting of the American Society of Hematology (ASH)

Strategies for Control of Multiple Myeloma Refined By New and Extended Data Analysis of Major Trials

New Orleans, Louisiana / December 7-10, 2013

New Orleans - Of data with practice-changing implications for control of multiple myeloma presented at ASH 2013, the most significant involved dosing of front-line therapy in those who are transplant-ineligible. In this group, it was shown...

PRIORITY PRESS - Annual Scientific Meeting of the American College of Gastroenterology

Update on Iron Deficiency Anemia in Gastrointestinal Disorders

San Diego, California / October 11-16, 2013

San Diego - Iron deficiency anemia (IDA) is widely prevalent among patients with gastrointestinal disease, mainly due to chronic blood loss as a result of mucosal damage, reduced duodenal absorption of dietary iron, and/or reduced dietary...

PRIORITY PRESS - 36th Annual San Antonio Breast Cancer Symposium (SABCS)

Advances in Endocrine Therapy for Breast Cancer

San Antonio, Texas / December 10-14, 2013

San Antonio - Endocrine therapy is an important weapon in a clinician’s armamentarium against metastatic breast cancer (mBC). Several endocrine therapies are considered standard for hormone receptor-positive (HR+) postmenopausal...

PAGE 10 OF 123   1 2 3 4 5 6 7 8 9 10 ...